SEC Form 4 · accession 0001209191-19-012777
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter J Graham
Officer — EVP General Counsel, Secretary
Period of report
Feb 20, 2019
Accepted (ET)
Feb 22, 2019 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2019 | A | 84,735 | $0.00 | A | 373,908 | D | |
| Common Stock | Feb 20, 2019 | F | 32,386 | $3.20 | D | 341,522 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 2, 2016, Mr. Graham was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three year performance period ended December 31, 2018. The number of shares acquired represent the total number of shares earned upon achievement of certain performance goals, the achievement of which was certified on February 20, 2019. The shares disposed represents the number of shares withheld to settle tax liability in connection with the vesting of the performance stock unit award.